Susquehanna International Group
ARRY

Susquehanna International Group’s Array Biopharma Inc ARRY Stock Holding History

Susquehanna International Group’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-690,300
Closed -$32M – 11268
2019
Q2 		$32M Buy
690,300
+125,200
+22% +$3.52M 0.01% 971
2019
Q1 		$13.8M Buy
565,100
+25,500
+5% +$531K 0.01% 1477
2018
Q4 		$7.69M Buy
539,600
+178,700
+50% +$2.71M ﹤0.01% 1844
2018
Q3 		$5.49M Sell
360,900
-49,200
-12% -$754K ﹤0.01% 2580
2018
Q2 		$6.88M Sell
410,100
-336,400
-45% -$5.35M ﹤0.01% 2355
2018
Q1 		$12.2M Buy
746,500
+393,600
+112% +$6.31M ﹤0.01% 1611
2017
Q4 		$4.52M Sell
352,900
-18,300
-5% -$208K ﹤0.01% 2649
2017
Q3 		$4.57M Sell
371,200
-7,300
-2% -$67.8K ﹤0.01% 2608
2017
Q2 		$3.17M Sell
378,500
-203,700
-35% -$1.67M ﹤0.01% 3063
2017
Q1 		$5.21M Buy
582,200
+380,200
+188% +$4.05M ﹤0.01% 2318
2016
Q4 		$1.78M Sell
202,000
-357,800
-64% -$2.63M ﹤0.01% 4321
2016
Q3 		$3.78M Buy
559,800
+379,100
+210% +$1.47M ﹤0.01% 2589
2016
Q2 		$643K Sell
180,700
-382,700
-68% -$1.25M ﹤0.01% 5687
2016
Q1 		$1.66M Sell
563,400
-357,500
-39% -$1.07M ﹤0.01% 4123
2015
Q4 		$3.89M Buy
920,900
+249,400
+37% +$1.14M ﹤0.01% 2877
2015
Q3 		$3.06M Buy
671,500
+249,000
+59% +$1.48M ﹤0.01% 3463
2015
Q2 		$3.05M Sell
422,500
-40,800
-9% -$301K ﹤0.01% 3818
2015
Q1 		$3.42M Buy
463,300
+222,500
+92% +$1.58M ﹤0.01% 3320
2014
Q4 		$1.14M Sell
240,800
-33,400
-12% -$132K ﹤0.01% 5592
2014
Q3 		$979K Buy
274,200
+207,100
+309% +$816K ﹤0.01% 5956
2014
Q2 		$306K Sell
67,100
-28,100
-30% -$116K ﹤0.01% 8351
2014
Q1 		$447K Sell
95,200
-35,900
-27% -$181K ﹤0.01% 6920
2013
Q4 		$657K Buy
+131,100
New +$714K ﹤0.01% 6258

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Susquehanna International Group's ARRY Position: Q3 2019 in Review

Susquehanna International Group sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 581,140 shares — an estimated $26.9M sold.

Susquehanna International Group first reported a position in ARRY in Q2 2013 and held it in 20 quarters. The position peaked at $26.9M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Susquehanna International Group reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Susquehanna International Group sold 581,140 Array Biopharma Inc shares in Q3 2019, an estimated $26.9M.
  • Susquehanna International Group first reported a position in Array Biopharma Inc in Q2 2013 and held it in 20 quarters.
  • Susquehanna International Group's Array Biopharma Inc position peaked at $26.9M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Susquehanna International Group's 13F filing for Q3 2019, filed 14 Nov 2019.